Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six-month naturalistic follow-up study

Schizophrenia Research

Volumn 130, Issue 1-3, 2011, Pages 176-181

  Baloush Kleinman, Vered ^a   Levine, Stephen Z ^b   Roe, David ^c   Shnitt, Dan ^d   Weizman, Abraham ^d   Poyurovsky, Michael ^e  

^a MINISTRY OF HEALTH   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adherence; Antipsychotic medication; Health Belief Model; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTITUDE TO MENTAL ILLNESS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EXTRAPYRAMIDAL SYMPTOM; FAMILY ATTITUDE; FEMALE; FOLLOW UP; HEALTH BELIEF MODEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; VISUAL ANALOG SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; PAIN MEASUREMENT; PATIENT DISCHARGE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 79960298257     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.04.030     Document Type: Article

References (48)

1. Adams J., Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr. Scand. 2000, 101(2):119-124.
2. Amador X.F., Flaum M., Andreasen N.C., Strauss D.H., Yale S.A., Clark S.C. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch. Gen. Psychiatry 1994, 51(10):826-836.
3. Anderson L.A., Dedrick R.F. Development of the trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol. Rep. 1990, 67(3 Pt 2):1091-1100.
4. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City.
5. Andreasen N.C. Scale for the assessment of negative symptoms (SANS). Br. J. Psychiatry 1989, 155(Suppl 7):53-58.
6. Appelbaum P.S., Grisso T. The MacArthur Treatment Competence Study I: Mental illness and competence to consent to treatment. Law Hum. Behav. 1995, 19(2):105-126.
7. Arbuckle J.L. Amos 5.0 [Computer software] 2003, Smallwaters, Chicago.
8. Ascher-Svanum H., Zhu B., Faries D., Lacro J.P., Dolder C.R. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J. Clin. Psychiatry 2006, 67(7):1114-1123.
9. Becker M.H., Maiman L.A. Sociobehavioral determinants of compliance with health and medical care recommendations. Med. Care 1975, 13(1):10-24.
10. Becker M.H., Maiman L.A. Strategies for enhancing patient compliance. J. Community Health 1980, 6(2):113-135.
11. Becker M.H., Haefner D.P., Kasl S.V., Kirscht J.P., Maiman L.A., Rosenstock I.M. Selected psychosocial models and correlates of individual health-related behaviors. Med. Care 1977, 15(5 SUPPL):27-46.
12. Becker M.H., Maiman L.A., Kirscht J.P., Haefner D.P., Drachman R.H. The Health Belief Model and prediction of dietary compliance: a field experiment. J. Health Soc. Behav. 1977, 18(4):348-366.
13. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Methodol. 1995, 57(1):289-300.
14. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychiatr. Med. 1992, 22:787-797.
15. Chouinard G., Margolese H.C. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr. Res. 2005, 76(2-3):247-265.
16. Coldham E.L., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr. Scand. 2002, 106(4):286-290.
17. Day J.C., Wood G., Dewey M., Bentall R.P. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br. J. Psychiatry 1995, 166(5):650-653.
18. De Smet B.D., Erickson S.R., Kirking D.M. Self-reported adherence in patients with asthma. Ann. Pharmacother. 2006, 40(3):414-420.
19. Deegan P.E. The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities. Scand. J. Public Health 2005, 66:29-35.
20. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 1997, 23(4):637-651.
21. Garber M.C., Nau D.P., Erickson S.R., Aikens J.E., Lawrence J.B. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med. Care 2004, 42(7):649-652.
22. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology 1976, US Department of Health, Education, and Welfare, Rockville, MD, Publication no. ADM 76-338.
23. Hogan T.P., Awad A.G., Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983, 13(1):177-183.
24. Hu L., Bentler P.M. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equation Model. 1999, 6(1):1-55.
25. Jeste S.D., Patterson T.L., Palmer B.W., Dolder C.R., Goldman S., Jeste D.V. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr. Res. 2003, 63(1-2):49-58.
26. Kamali M., Kelly B.D., Clarke M., Browne S., Gervin M., Kinsella A., Lane A., Larkin C., O'Callaghan E. A prospective evaluation of adherence to medication in first episode schizophrenia. Europ. Psych. 2006, 21:29-33.
27. Kessler T.A. The Cognitive Appraisal of Health Scale: development of psychometric evaluation. Res. Nurs. Health 1998, 21(1):73-82.
28. Kirscht J.P., Marshall H., Becker M.H., Haefner D.P., Maiman L.A. Effects of threatening communications and mothers' health beliefs on weight change in obese children. J. Behav. Med. 1978, 1(2):147-157.
29. Kline R.B. Principles and Practice of Structural Equation Modeling 2005, The Guilford Press.
30. Leucht S., Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J. Clin. Psychiatry 2006, 67(Suppl 5):3-8.
31. Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am. J. Psychiatry 2003, 160(7):1209-1222.
32. Levine S.Z., Rabinowitz J., Engel R., Etschel E., Leucht S. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI. Schizophr. Res. 2008, 98(1-3):318-322.
33. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353(12):1209-1223.
34. Lin A.S., Chen C.H., Hwu H.G., Lin H.N., Chen J.A. Psychopathological dimensions in schizophrenia: a correlational approach to items of the SANS and SAPS. Psychiatry Res. 1998, 77(2):121-130.
35. Maiman L.A., Wang V.L., Becker M.H., Finlay J., Simonson M. Attitudes toward obesity and the obese among professionals. J. Am. Diet. Assoc. 1979, 74(3):331-336.
36. Maiman L.A., Becker M.H., Cummings K.M., Drachman R.H., O'Connor P.A. Effects of sociodemographic and attitudinal factors on mother-initiated medication behavior for children. Public Health Rep. 1982, 97(2):140-149.
37. McEvoy J.P., Howe A.C., Hogarty G.E. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients. J. Nerv. Ment. Dis. 1984, 172(7):412-416.
38. Olfson M., Marcus S.C., Wilk J., West J.C. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatr. Serv. 2006, 57(2):205-211.
39. Rabinowitz J., Levine S.Z., Barkai O., Davidov O. Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features. Schizophr. Bull. 2009, 35(4):775-788.
40. Roe D., Swarbrick M. A recovery-oriented approach to psychiatric medication: guidelines for nurses. J. Psychosoc. Nurs. Ment. Health Serv. 2007, 45(2):35-40.
41. Roe D., Goldblatt H., Baloush-Klienman V., Swarbrick P., Davidson L. Why and how do people with a serious mental illness decide to stop taking their medication: exploring the subjective process of making and activating a choice. Psychiatr. Rehabil. J. 2009, 33:366-374.
42. Sapra M., Vahia I.V., Reyes P.N., Ramirez P., Cohen C.I. Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia. Schizophr. Res. 2008, 106(2-3):348-355.
43. Smith J., Birchwood M., Haddrell A. Informing people with schizophrenia about their illness: the effect of residual symptoms. J. Ment. Health 1992, 1(1):61-70.
44. Swartz M.S., Swanson J.W., Hiday V.A., Borum R., Wagner H.R., Burns B.J. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am. J. Psychiatry 1998, 155(2):226-231.
45. Velligan D.I., Lam Y.W., Glahn D.C., Barrett J.A., Maples N.J., Ereshefsky L. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 2006, 32(4):724-742.
46. Verdoux H., Lengronne J., Liraud F., Gonzales B., Assens F., Abalan F. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr. Scand. 2000, 102(3):203-210.
47. Wong J.G., Clare I.C.H., Holland A.J., Watson P.C., Gunn M. The capacity of people with a mental disability to make a health care decision. Psychol. Med. 2000, 30:295-306.
48. Zygmunt A., Olfson M., Boyer C.A., Mechanic D. Interventions to improve medication adherence in schizophrenia. Am. J. Psychiatry 2002, 159(10):1653-1664.